Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

    Fundamental and Clinical Pharmacology, Vol. 38, Núm. 1, pp. 183-191

2023

  1. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview

    Cancers, Vol. 15, Núm. 4

  2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

    Cancers, Vol. 14, Núm. 5

  2. Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2018

  1. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 6, Núm. 3, pp. 193-203

2017

  1. The accuracy of postoperative, non-invasive Air-Test to diagnose atelectasis in healthy patients after surgery: A prospective, diagnostic pilot study

    BMJ Open, Vol. 7, Núm. 5